Douglas Lowy

Doug Lowy receives Science of Oncology Award and Lecture from the American Society of Clinical Oncology

Mar 15, 2018

Doug Lowy, M.D., Deputy Director of the National Cancer Institute and Chief of the Laboratory of Cellular Oncology, has received the Science of Oncology Award and Lecture from the American Society of Clinical Oncology (ASCO). The award recognizes outstanding contributions to basic or translational research in cancer and is one of ASCO’s most prestigious awards for leadership and exceptional service to transform cancer care around the world. Dr. Lowy will be honored during ASCO’s Annual Meeting in June in Chicago. Read more...

Doug Lowy receives Science of Oncology Award and Lecture from the American Society of Clinical Oncology
WSJ logo

Jeremy Davis featured in Wall Street Journal article on preventive surgery for stomach cancer

Mar 13, 2018

The Wall Street Journal recently reported on the growing number of individuals with a family history of stomach cancer who choose to undergo genetic testing or total stomach removal as a preventive measure. The article features Jeremy Davis, M.D., Staff Clinician in the Thoracic and Gastrointestinal Oncology Branch and Surgeon-in-Chief at the NIH Clinical Center, who notes that researchers have quite a bit to learn about a mutation in the CDH1 gene linked to an increased risk of a certain type of stomach cancer. Read the full article…

Jeremy Davis featured in Wall Street Journal article on preventive surgery for stomach cancer
Scientists

New collaborative study will explore health disparities for prostate cancer

Feb 26, 2018

A newly funded study aims to explore the relationship between chronic inflammation, ancestry and tumor biology as a cause of prostate cancer progression in men of African descent who experience a disproportionately high prostate cancer mortality rate in the U.S. and globally. As a collaborative project between NCI and external researchers, Stefan Ambs, Ph.D., M.P.H, Senior Investigator in CCR’s Laboratory of Human Carcinogenesis, will lead the study with Michael Cook, Ph.D., of NCI’s Division of Cancer Epidemiology and Genetics and Clayton Yates, Ph.D., of Tuskegee University to help address health disparities for prostate cancer. The project is funded through a Prostate Cancer Research Program Impact Award from the Department of Defense. Read more...

New collaborative study will explore health disparities for prostate cancer
Scientists in lab

Three CCR accomplishments receive Excellence in Technology Transfer Awards

Feb 23, 2018

The Federal Laboratory Consortium for Technology Transfer has recognized three CCR accomplishments with Excellence in Technology Transfer Awards. This award category honors employees of FLC member laboratories and non-laboratory staff who have accomplished outstanding work in the process of transferring federally developed technology. Read more…

Dr. Michael Gottesman

Michael Gottesman receives the Dr. Nathan Davis Award for Outstanding Government Service

Feb 20, 2018

Michael Gottesman, M.D., Chief of the Laboratory of Cell Biology, has received the Dr. Nathan Davis Award for Outstanding Government Service from the American Medical Association (AMA) for his contributions to public health, medical science and the training of physician-scientists. As the AMA’s top government service award, the Dr. Nathan Davis Award recognizes elected and career officials in federal, state or municipal service whose outstanding contributions have promoted the art and science of medicine and the betterment of public health. Read more…

Michael Gottesman receives the Dr. Nathan Davis Award for Outstanding Government Service
Lowy and Schiller

Doug Lowy and John Schiller receive the Szent-Györgyi Prize for Progress in Cancer Research

Feb 15, 2018

The National Foundation for Cancer Research (NFCR) will honor CCR’s Doug Lowy, M.D., Chief of the Laboratory of Cellular Oncology, and John Schiller, Ph.D., Deputy Chief of the Laboratory of Cellular Oncology, with the Szent-Györgyi Prize for Progress in Cancer Research during a ceremony on May 5 in Washington, D.C. The annual prize, named after NFCR’s co-founder, Albert Szent-Györgyi, M.D., Ph.D., honors scientists who have made an original discovery or breakthrough in scientific understanding that has had a lasting impact on the cancer field and saving people’s lives. In addition to the more than 150 papers co-authored by Drs. Lowy and Schiller, the duo’s research has led to great advances in understanding HPV infection and the development of three preventive HPV vaccines approved by the U.S. Food and Drug Administration. Read more…

Doug Lowy and John Schiller receive the Szent-Györgyi Prize for Progress in Cancer Research
ASCO logo

CCR scientists help develop first recommendations for managing mesothelioma

Feb 7, 2018

Anish Thomas, M.B.B.S., M.D., Investigator in the Developmental Therapeutics Branch, Markku Martti Miettinen, M.D., Ph.D., Senior Clinician in the Laboratory of Pathology, and Raffit Hassan, M.D., Co-Chief of the Thoracic and Gastrointestinal Oncology Branch, are among the contributing authors of the American Society of Clinical Oncology’s first guidelines for evidence-based recommendations on the management of mesothelioma. The guidelines were informed by 222 relevant studies. The recommendations were developed for diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy and multimodality therapy in patients with mesothelioma. Learn more…

CCR scientists help develop first recommendations for managing mesothelioma
Kenneth Aldape, M.D.

Ken Aldape joins CCR as Chief, Laboratory of Pathology

Feb 5, 2018

Kenneth Aldape, M.D., has joined CCR as the Chief of the Laboratory of Pathology. Dr. Aldape’s research interests focus on the molecular pathogenesis and classification of brain tumors, particularly malignant gliomas and meningliomas. His passion is to apply new molecular technologies to classify tumors from a biological perspective. Learn more...

Ken Aldape joins CCR as Chief, Laboratory of Pathology
Dr. Yves Pommier

Yves Pommier named fellow of the American Association for the Advancement of Science

Jan 23, 2018

Yves Pommier, M.D., Ph.D., Chief of the Developmental Therapeutics Branch, was recently elected a fellow of the American Association for the Advancement of Science (AAAS). Election as a fellow honors AAAS members whose efforts to advance science or its applications have distinguished them among their peers and colleagues. The 2017 AAAS Fellows will be recognized on Feb. 17, 2018 at the AAAS annual meeting in Austin, TX. Read more...

Yves Pommier named fellow of the American Association for the Advancement of Science
Dr. Michael Gottesman

Michael Gottesman honored with Order of the Rising Sun by Japanese Government

Jan 19, 2018

The Government of Japan recently honored Michael Gottesman, M.D., Chief of the Laboratory of Cell Biology, with the Order of the Rising Sun, Gold Rays and Neck Ribbon, for his contributions toward promoting research exchange in the biomedical field between the U.S. and Japan. The Order of the Rising Sun was established in 1875 as the first national decoration awarded by the Japanese government. Read more...

Michael Gottesman honored with Order of the Rising Sun by Japanese Government

Pages